PCR and molecular assays at EBF 2026

Nov 17–19, 2026 Barcelona, Spain ~800 attendees Website

8 organizations at EBF 2026 present work in PCR and other molecular assays: 6 CROs and suppliers and 2 drug developers. Between them they bring 14 presentations to the program. Most represented: BioAgilytix (4 on the program), ICON (4 on the program), Labcorp (2 on the program). 7 of them have their own page in this guide. As of Oct 13, 2026.

All 63 organizations at EBF 2026 →

Showing 1–8 of 8 organizations

Organization	EBF 2026 Attendance
BioAgilytix Durham, North Carolina	◇Sponsor
bioagilytix.com Bioanalytical CROsSponsor Bioanalytical CRO specialising in large-molecule PK, immunogenicity, biomarker and cell-based assays, with labs in the US and Europe.	Talk Tue Nov 17 11:50am–12:10pm Part of Session 2: Smarter Workflows: From Implementation to Scientific Confidence Fit-for-Purpose Implementation of a Generic Preclinical PK Assay: Lessons from Platform Transfer and Troubleshooting Ligand binding Talk Tue Nov 17 5:40–6pm Part of Session 9: New technologies and emerging modalities in Bioanalysis: PCR Considering DNA & RNA Extraction for PCR-Based Assay Validations PCR Talk Wed Nov 18 12:20–12:40pm Part of Session 13: BioA Clinic Cross-Platform Evaluation of Total Antibody and Total ADC PK: LBA versus LC-MS New modalities · LC–MS Talk Thu Nov 19 11:10–11:30am Part of Session 20: Pushing the Limits of Sensitivity and Multiplexing in Bioanalysis Responding to Evolving Clinical Needs: A Collaborative Journey to an Ultra-Sensitive PK Assay Ligand binding
ICON Dublin, Ireland	◇Sponsor
iconplc.com Bioanalytical CROsSponsor Global clinical research organization whose laboratories run central lab and regulated bioanalysis services.	Talk Tue Nov 17 4:20–4:40pm Part of Session 9: New technologies and emerging modalities in Bioanalysis: PCR How to validate qPCR assays in rare matrix such as ocular epithelial cells PCR Talk Thu Nov 19 9:20–9:40am Part of Session 15: Flow Implementation and validation of a 25-color immunophenotyping backbone with modular expansion toward 40-color spectral flow cytometry Cell-based Talk Thu Nov 19 9:40–10am Part of Session 16: Protein MS tech 1 The use of multiple signature peptides for quantitative protein bioanalysis by digestion and LC-MS/MS LC–MS Talk Thu Nov 19 2:40–3pm Part of Session 21: Protein MS Tech 2 Analytical aspects of LC-MS/MS-based neutralizing antibody testing LC–MS · Immunogenicity
Labcorp Burlington, North Carolina	◇Sponsor
labcorp.com Bioanalytical CROsSponsor Laboratory services company whose drug development unit runs central lab, bioanalysis and early development services.	Talk Tue Nov 17 2:40–3pm Part of Session 4: Advancing the 3Rs: Smarter Sampling, Surrogate Matrices and Leaner Workflows From Collection to Analysis: Evaluating Patient-Centric Dried Blood Microsampling Technologies for Regulated Bioanalysis Sampling Talk Tue Nov 17 5:20–5:40pm Part of Session 9: New technologies and emerging modalities in Bioanalysis: PCR Measuring Biological Response Using RT-qPCR: A Bioanalytical Perspective on Relative Gene Expression PCR · Biomarkers
UCB Brussels, Belgium
ucb.com Pharma Biopharmaceutical company developing medicines for immunology and neurology, including epilepsy and inflammatory diseases.	Talk Tue Nov 17 3–3:20pm Part of Session 4: Advancing the 3Rs: Smarter Sampling, Surrogate Matrices and Leaner Workflows Routine use of surrogate matrix in regulated bioanalysis Sampling Talk Tue Nov 17 5–5:20pm Part of Session 9: New technologies and emerging modalities in Bioanalysis: PCR Overcoming tissue matrix interference in a droplet digital PCR analytical method for biodistribution assessment PCR
Kymos	◇Sponsor
kymos.com Bioanalytical CROsSponsor Spanish CRO providing regulated bioanalysis, analytical development and quality-control testing for drug developers.	Talk Tue Nov 17 6–6:20pm Part of Session 9: New technologies and emerging modalities in Bioanalysis: PCR A Case Study in qPCR Bioanalysis of Viral vectors: Overcoming Matrix Effects and Extraction Challenges Using Automated Nucleic Acid Extraction PCR · New modalities
Johnson & Johnson Innovative Medicine
jnj.com Pharma Johnson & Johnson's pharmaceutical business, formerly Janssen.	Talk Tue Nov 17 4:40–5pm Part of Session 9: New technologies and emerging modalities in Bioanalysis: PCR Automating qPCR Workflow: Investigation and Resolution of Over-Recovery from Low-Copy Numbers During Workflow Development PCR · Automation & AI
Bio-Rad Hercules, California	◇Sponsor
bio-rad.com Instruments, reagents & softwareSponsor Makes life science research and clinical diagnostics products, including antibodies, immunoassay reagents and droplet digital PCR systems.	Sponsor In the meeting’s sponsor directory, with no session on the public program
TATAA Biocenter Gothenburg, Sweden	◇Sponsor
tataa.com Bioanalytical CROsSponsor Molecular analysis lab offering qPCR, digital PCR and sequencing services under GLP, plus training in molecular methods.	Sponsor In the meeting’s sponsor directory, with no session on the public program